# Oxford University

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/oxford-university
Canonical HTML page: https://getbiobrief.com/entity/oxford-university

## Timeline

- **2026-07-27**: 3,000 Cases Milestone — Total cases reach 3,075, with 1,354 deaths, amid healthcare strikes and calls for accelerated countermeasure development.
- **2026-07-24**: First Experimental Vaccine Volunteer Dosed — Oxford University reports that the first volunteer group has received its candidate vaccine specifically targeting Bundibugyo.
- **2026-07-15**: 2,000 Cases Surpassed — Cumulative confirmed cases exceed 2,000, with rapid spread noted in conflict zones.
- **2026-05-15**: Outbreak Declared — DR Congo announces its 17th Ebola outbreak, identifying the Bundibugyo strain as the cause.

## Recent coverage (1 stories)

### Ebola Outbreak Tops 3,000 Cases, Oxford Starts Clinical Trial for Bundibugyo Vaccine
2026-07-27 09:57:21 · Sentiment: Very Bearish · Impact: 7/10 · Sources: 2

DRC’s 17th Ebola outbreak has exploded to 3,075 cases and 1,354 deaths, with 1,000 new infections in just 10 days. The Bundibugyo strain has no approved vaccine or treatment, igniting a biotech race: Oxford University has dosed its first volunteer with an experimental vaccine, while other candidates are fast-tracked, creating high-stakes opportunities for pharma developers.
Full story: https://getbiobrief.com/story/ebola-outbreak-3000-cases-bundibugyo-vaccine-clinical-trial

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.